Russia plans to approve COVID vaccine still in trial

Russia is rushing to win the race to develop a vaccine against the novel Coronavirus, and in the process has planned to approve by early August a vaccine that is still in the trial phase, according to a report in CNN.

The vaccine, being developed by Gamaleya Institute in Moscow, is likely to be approved for public use on...